SpIntellx retweeted
Inspirata is pleased to announce its new partnership with @SpIntellx at #APC2022! To learn more about this exciting collaboration, swing by Booth 18 or click here: inspirata.link/APC22PR
#pathology #digitalpathology #momentsmatter
We are looking forward to meeting you in-person at @apcprods Annual Meeting 2022, July 17-20, #APC2022 in #Chicago! Our leadership team, Dusty Majumdar, CEO, and S. Chakra Chennubhotla, CTO & Co-founder will be there in-person to connect for conversations on #PrecisionPathology
1
Today we announced the appointment of our new CEO, Dusty Majumdar, PhD at SpIntellx. We welcome Dusty to our amazing team and look forward to the next phase of our exciting journey with researchers and clinicians.
prweb.com/releases/2022/05/p…
Great to have met so many pioneers in #CancerResearch at @AACR Annual Meeting 2022 interested in our next generation spatial analytics going beyond conventional computational pathology: #PrecisionPathology. #AACR22 #AACR2022 linkedin.com/posts/spintellx…
Thanks for the huge interest in our poster #454 “TumorMapr: Unbiased Spatial Analytics and Explainable AI (xAI) Powers Precision Pathology” yesterday at @AACR 2022 Annual Meeting.
Stop by our booth #3028 to learn more about #TumorMapr and #HistoMapr. linkedin.com/posts/spintellx…
Get two steps ahead in #PrecisionPathology with Unbiased Spatial Analytics and Explainable AI.
Meet us at the poster #454 today and visit our booth #3028 at the @AACR Annual Meeting 2022 linkedin.com/posts/spintellx… #AACR2022 #aacr22 #aacr
We are looking forward to meeting you in-person at @AACR Annual Meeting 2022, New Orleans, April 10-13
Booth #3028 & Poster #454
linkedin.com/feed/update/urn…
#aacr2022 #aacr #aacr22 #PrecisionPathology #spatialanalytics #explainableAI
#Spatial intratumoral #heterogeneity is a key determinant of cancer progression.
linkedin.com/posts/spintellx…
Truly #unbiased and fully #automated discovery of #microdomains, functional units of spatial tissue heterogeneity, with proprietary explainable AI TumorMapr™ platform to accurately predict disease progression and response to therapy.
linkedin.com/feed/update/urn…
The truly #unbiased, #automated, #explainable, and #proprietary functional cell #phenotyping approach for multi-hyperplexed fluorescence and mass spectrometry image datasets from SpIntellx.
More on LinkedIn: linkedin.com/feed/update/urn…
The challenge of correctly #phenotyping cells, including fusion cell types, transitional and multi-transitional cell states, requires unbiased and automated functional cell phenotyping offered by the SpIntellx platform, #TumorMapr-Advanced™
linkedin.com/feed/update/urn…
1
You might want to follow us on LinkedIn. linkedin.com/company/spintel…
SpIntellx retweeted
Give it up for Chakra, Co-Founder & CEO of @SpIntellx, who spoke at #PMWC2021 last week! 👏👏
If you missed the presentation, you can learn more about this AlphaLab Health #AlumniCompany at: spintellx.com
We are pleased to announce the publication of a proprietary, unbiased, automated and spatial analytics driven functional cell phenotyping approach in the latest issue of @CellRepMethods @CellPressNews.
linkedin.com/posts/spintellx…
#PrecisionMedicine #SpatialProteomics #CompPath
Read the paper: cell.com/cell-reports-method…
Join us for a webinar on the #TumorMapr™ analytical software platform – the most powerful unbiased spatial analytics and explainable artificial intelligence (xAI) platform in the market.
Register here: us06web.zoom.us/webinar/regi…
Mark your calendars for #September13. Join us for a webinar on the #TumorMapr™ analytical software platform – the most powerful unbiased spatial analytics and explainable artificial intelligence (xAI) platform.
linkedin.com/feed/update/urn…
Introducing the #TumorMapr™ software platform – the most powerful unbiased spatial analytics and explainable AI platform for creating knowledge from multi to hyperplexed fluorescence and/or mass spectrometry image datasets.
linkedin.com/feed/update/urn…
1









